Fact or fiction: the need for independent pharmaceutical policy research.
作者信息
Keyhani Salomeh, Federman Alex
出版信息
J Gen Intern Med. 2009 May;24(5):692-4. doi: 10.1007/s11606-009-0964-2.
PMID:19343457
Abstract
摘要
相似文献
[1]
Fact or fiction: the need for independent pharmaceutical policy research.
J Gen Intern Med. 2009-5
[2]
[Developments by pharmaceutical companies].
Tijdschr Diergeneeskd. 2001-2-1
[3]
[4]
New countermeasures considered as drug counterfeiting grows.
Nat Med. 2008-7
[5]
Biosimilars and the long game.
Trends Biotechnol. 2015-5
[6]
[Clinical researchers and pharmaceutical industry. The examples of troglitazone and mibefradil].
Ned Tijdschr Geneeskd. 1999-8-21
[7]
Back to the future: driving innovation in drug development.
Clin Pharmacol Ther. 2008-2
[8]
The use of imaging to accelerate drug development.
Drug Discov Today. 2002-7-1
[9]
引用本文的文献
[1]
本文引用的文献
[1]
Do new drugs increase life expectancy? A critique of a Manhattan Institute paper.
J Gen Intern Med. 2009-3-24
[2]
The ADVANTAGE seeding trial: a review of internal documents.
Ann Intern Med. 2008-8-19
[3]
[4]
Cholesterol lowering and ezetimibe.
N Engl J Med. 2008-4-3
[5]
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
N Engl J Med. 2008-4-3
[6]
Australian pharmaceutical policy: price control, equity, and drug innovation in Australia.
J Public Health Policy. 2008-4
[7]
[8]
Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance.
Health Aff (Millwood). 2008
[9]
[10]
Developing a center for comparative effectiveness information.
Health Aff (Millwood). 2006
Zotero 插件